Breaking News Headlines Today

News about Amgen

Stay current with all the latest and breaking news about Amgen, compare headlines and perspectives between news sources on stories happening today. In total, 67 stories have been published about Amgen which Ground News has aggregated in the past 3 months.

Covered Most By

Helena Independent Record

Center

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs

100% Center coverage: 2 sources

Alveus Therapeutics’ Phase 2-ready lead drug hits the same two targets as Amgen’s MariTide, but with the potential for a dosing advantage. The startup’s pipeline also includes molecules that could compete with drugs in development by Roche and Novo Nordisk. The post Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs appeared first on MedCity News.See the Story

Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs

100% Center coverage: 2 sources

Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen

Oncology, an industry awash with ever-more sophisticated drugs, has a target problem. Industry reports from 2025 reveal that oncology R&D is highly concentrated, with ~25% of drug-target pairs targeting 38 targets and over 80% of cancer targets facing multiple competing clinical candidates. In other words, oncology R&D primarily concentrates on a tiny slice of the (theoretically) druggable world. This extremely limited target set is rooted in a …Amgen · Switzerland Read Article

Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more

100% Center coverage: 1 sources

Check out some of the biggest movers in midday trading.Stock Markets Read Article

Cancer biotech Disco lines up Amgen as first pharma partner

A small German and Swiss biotech working on antibody-drug conjugates and T cell engagers has inked its first big pharma partnership shortly after nabbing a new CEO and seed round extension. Amgen will create new ...Amgen · Germany Read Article

Lilly in Talks to Buy Ventyx Biosciences for More than $1 ...

78% Center coverage: 18 sources

Ventyx shares jumped in after-hours trading following reports that Eli Lilly is in advanced talks to acquire the biopharma company for over $1 billion.Eli Lilly · San Diego See the Story

Amgen inks $840m takeover of UK's Dark Blue Therapeutics

100% Center coverage: 1 sources

Amgen has added a new acute myeloid leukaemia drug with the takeover of Dark Blue Therapeutics and its first-in-class MLLT 1/3 degrader.Amgen · United Kingdom Read Article

Dark Blue Therapeutics acquired by Amgen for up to $840 million

67% Center coverage: 6 sources

Lead candidate in the MLLT1/3 programme, DBT 3757, is a differentiated investigational molecule designed to treat Acute Myeloid Leukemia Acquisition brings a...Amgen See the Story

What to Expect From Xylem's Q4 2025 Earnings Report

Xylem will release its fourth-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.Amgen Read Article

Zenas BioPharma Touts Phase 3 Win, But Stock Crashes - Zenas BioPharma (NASDAQ:ZBIO)

100% Center coverage: 3 sources

Zenas BioPharma shares fall after Phase 3 obexelimab data in IgG4-RD showed a 56% flare risk reduction, as investors weigh competition from Amgen's FDA-approved Uplizna.Amgen See the Story

Permission Sought for Construction of Ballroom at Donald Trump’s Co Clare Resort

83% Left coverage: 6 sources

Decision on plans for US president’s Doonbeg resort submitted to Clare County Council due in FebruaryDonald Trump See the Story

News about Amgen

News about Amgen

Covered Most By

Local News Publishers

Top Amgen News

Lilly in Talks to Buy Ventyx Biosciences for More than $1 ...

Dark Blue Therapeutics acquired by Amgen for up to $840 million

Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs

Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs

Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen

Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more

Cancer biotech Disco lines up Amgen as first pharma partner

Lilly in Talks to Buy Ventyx Biosciences for More than $1 ...

Amgen inks $840m takeover of UK's Dark Blue Therapeutics

Dark Blue Therapeutics acquired by Amgen for up to $840 million

What to Expect From Xylem's Q4 2025 Earnings Report

Zenas BioPharma Touts Phase 3 Win, But Stock Crashes - Zenas BioPharma (NASDAQ:ZBIO)

Permission Sought for Construction of Ballroom at Donald Trump’s Co Clare Resort

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Amgen

Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs

Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen

Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more

Cancer biotech Disco lines up Amgen as first pharma partner

Lilly in Talks to Buy Ventyx Biosciences for More than $1 ...

Amgen inks $840m takeover of UK's Dark Blue Therapeutics

Dark Blue Therapeutics acquired by Amgen for up to $840 million

What to Expect From Xylem's Q4 2025 Earnings Report

Zenas BioPharma Touts Phase 3 Win, But Stock Crashes - Zenas BioPharma (NASDAQ:ZBIO)

Permission Sought for Construction of Ballroom at Donald Trump’s Co Clare Resort

News about Amgen

News about Amgen

Covered Most By

Local News Publishers Too Big Arrow Icon

Top Amgen News

Lilly in Talks to Buy Ventyx Biosciences for More than $1 ...

Dark Blue Therapeutics acquired by Amgen for up to $840 million

Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs

Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs

Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen

Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more

Cancer biotech Disco lines up Amgen as first pharma partner

Lilly in Talks to Buy Ventyx Biosciences for More than $1 ...

Amgen inks $840m takeover of UK's Dark Blue Therapeutics

Dark Blue Therapeutics acquired by Amgen for up to $840 million

What to Expect From Xylem's Q4 2025 Earnings Report

Zenas BioPharma Touts Phase 3 Win, But Stock Crashes - Zenas BioPharma (NASDAQ:ZBIO)

Permission Sought for Construction of Ballroom at Donald Trump’s Co Clare Resort

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Amgen

Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs

Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen

Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more

Cancer biotech Disco lines up Amgen as first pharma partner

Lilly in Talks to Buy Ventyx Biosciences for More than $1 ...

Amgen inks $840m takeover of UK's Dark Blue Therapeutics

Dark Blue Therapeutics acquired by Amgen for up to $840 million

What to Expect From Xylem's Q4 2025 Earnings Report

Zenas BioPharma Touts Phase 3 Win, But Stock Crashes - Zenas BioPharma (NASDAQ:ZBIO)

Permission Sought for Construction of Ballroom at Donald Trump’s Co Clare Resort

Local News Publishers